UH Drug Discovery Institute

ARPA-H has awarded a team of researchers across seven states $45 million to develop technology that could cut U.S. cancer-related deaths in half. Weiyi Peng, assistant professor of biology and biochemistry, is co-principal investigator and one of three group leaders of the project.